Position in DYN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,003,176
-$710,124 QoQ
Shares Held
496,590
0.0% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,156,213,147 across 116 Biotechnology names. DYN ranks #36 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,003,176 | 496,590 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,713,300 | 496,590 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $254,897 | 20,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,533,014 | 266,073 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $210,769 | 20,150 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,435,583 | 315,602 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,234,051 | 312,752 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,037,018 | 312,752 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,354,608 | 611,293 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,800,196 | 511,293 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,581,185 | 511,293 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,752,046 | 511,293 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,610,731 | 226,626 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $463,600 | 40,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $562,229 | 44,270 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $274,800 | 40,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $385,600 | 40,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $475,600 | 40,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $649,600 | 40,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $841,600 | 40,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $621,200 | 40,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $840,000 | 40,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $807,600 | 40,000 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||